Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2025 ▲▼ | Q3 2025 ▲▼ | Change ▲▼ | Q2 2025 ▲▼ | Q3 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Mineralys Therapeutics, Inc.(MLYS) | 79,000 | 39,000 | -40,000 | $1.07M | $1.48M | 8.40% | +$410.0K |
| Milestone Pharmaceuticals Inc.(MIST) | 548,806 | 658,553 | +109,747 | $1.06M | $1.32M | 7.48% | +$252.4K |
| Fennec Pharmaceuticals Inc.(FENC) | 195,700 | 123,000 | -72,700 | $1.62M | $1.15M | 6.54% | -$473.0K |
| Jasper Therapeutics, Inc.(JSPR) | 146,500 | 398,558 | +252,058 | $813.1K | $948.6K | 5.39% | +$135.5K |
| Avadel Pharmaceuticals Plc | 98,700 | 59,700 | -39,000 | $873.5K | $911.6K | 5.18% | +$38.1K |
| Kiniksa Pharmaceuticals International, plcCL A(KNSA) | 45,900 | 23,400 | -22,500 | $1.27M | $908.6K | 5.16% | -$361.4K |
| Insmed Incorporated(INSM) | 10,650 | 6,250 | -4,400 | $1.07M | $900.1K | 5.11% | -$171.8K |
| Ardelyx Inc | 335,400 | 162,750 | -172,650 | $1.31M | $896.8K | 5.09% | -$418.0K |
| Benitec Biopharma Inc.(BNTC) | 62,000 | 62,000 | 0 | $725.4K | $869.9K | 4.94% | +$144.5K |
| Syndax Pharmaceuticals, Inc.(SNDX) | 55,000 | 55,000 | 0 | $515.1K | $846.2K | 4.81% | +$331.1K |
| Royalty Pharma plcCL A(RPRX) | 0 | 21,400 | +21,400 | $0 | $755.0K | 4.29% | +$755.0K |
| Disc Medicine, Inc.(IRON) | 10,600 | 10,600 | 0 | $561.4K | $700.4K | 3.98% | +$139.1K |
| BridgeBio Pharma, Inc.(BBIO) | 26,000 | 13,300 | -12,700 | $1.12M | $690.8K | 3.92% | -$431.9K |
| Geron Corporation(GERN) | 500,000 | 500,000 | 0 | $705.0K | $685.0K | 3.89% | -$20.0K |
| Arcutis Biotherapeutics, Inc.(ARQT) | 46,300 | 35,300 | -11,000 | $649.1K | $665.4K | 3.78% | +$16.3K |
| REGENXBIO Inc.(RGNX) | 57,750 | 57,750 | 0 | $474.1K | $557.3K | 3.17% | +$83.2K |
| Seres Therapeutics, Inc.(MCRB) | 17,038 | 27,138 | +10,100 | $189.3K | $522.1K | 2.97% | +$332.8K |
| MoonLake ImmunotherapeuticsCL A(MLTX) | 0 | 67,500 | +67,500 | $0 | $484.0K | 2.75% | +$484.0K |
| Kura Oncology, Inc.(KURA) | 0 | 46,000 | +46,000 | $0 | $407.1K | 2.31% | +$407.1K |
| Biohaven Ltd.(BHVN) | 22,700 | 22,700 | 0 | $320.3K | $340.7K | 1.94% | +$20.4K |
| COMPASS Pathways plcADS(CMPS) | 0 | 58,000 | +58,000 | $0 | $332.3K | 1.89% | +$332.3K |
| Praxis Precision Medicines, Inc.(PRAX) | 0 | 5,700 | +5,700 | $0 | $302.1K | 1.72% | +$302.1K |
| Day One Biopharmaceuticals I COM | 0 | 42,000 | +42,000 | $0 | $296.1K | 1.68% | +$296.1K |
| Rocket Pharmaceuticals, Inc.(RCKT) | 0 | 86,000 | +86,000 | $0 | $280.4K | 1.59% | +$280.4K |
| Mersana Therapeutics Inc | 0 | 25,760 | +25,760 | $0 | $199.9K | 1.14% | +$199.9K |
| Humacyte, Inc.(HUMA) | 83,500 | 83,500 | 0 | $174.5K | $145.3K | 0.83% | -$29.2K |
| Spruce Biosciences Inc | 0 | 1,000 | +1,000 | $0 | $8.9K | 0.05% | +$8.9K |
| Mersana Therapeutics Inc | 644,000 | 0 | -644,000 | $190.6K | $0 | — | -$190.6K |